Receptos treats first patient in RPC1063 Phase 1 trial
The study is being conducted in healthy male and female volunteers at a single site in the US under an investigational new drug (IND) application recently allowed by
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
PureNano combines a machine with expert process development to obtain smaller and more consistent particle sizes for several applications including pharmaceutical and energy industries. The PureNano Continuous Crystallizer